[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341230-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341230-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","foxf1-promotes-tumor-vessel-normalization-and-prevents-lung-cancer-progression-through-fzd4","FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4","","Cancer cells re-program normal lung endothelial cells (EC) into tumor-associated endothelial cells (TEC) that form leaky vessels supporting carcinogenesis. Transcriptional regulators controlling EC-to-TEC reprogramming remain poorly defined. Forkhead box F1 (FOXF1) is identified as a critical regulator, with reduced FOXF1 in TEC of non-small cell lung cancer (NSCLC). In mice, endothelial-specific FOXF1 loss worsens vascular leakage, hypoxia, tumor growth, and metastasis, while FOXF1 restoration normalizes vessels and inhibits progression. Mechanistically, FOXF1 activates Fzd4 transcription and rescues Wnt/β-catenin signaling via endothelial nanoparticle delivery of Fzd4 cDNA.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/foxf1-promotes-tumor-vessel-normalization-and-prevents-lung-cancer-progression-through-fzd4/341230/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/foxf1-promotes-tumor-vessel-normalization-and-prevents-lung-cancer-progression-through-fzd4/341230.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does FOXF1 play in tumor-associated endothelial cells (TEC)?","Question",{"text":63,"@type":64},"FOXF1 is a critical regulator of the EC-to-TEC transition. It supports tumor vessel stability and inhibits lung cancer progression by promoting downstream signaling.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does FOXF1 loss affect lung tumors in vivo?",{"text":68,"@type":64},"Endothelial-specific deletion of FOXF1 decreases pericyte coverage, increases vessel permeability and hypoxia, and promotes lung tumor growth and metastasis.",{"name":70,"@type":61,"acceptedAnswer":71},"How is FZD4 linked to FOXF1 and Wnt/β-catenin signaling?",{"text":72,"@type":64},"FOXF1 directly activates Fzd4 transcription in TECs, which increases Wnt/β-catenin signaling. Restoring FZD4 via endothelial nanoparticle delivery rescues signaling and normalizes tumor vessels.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341230,1790457683,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","Article  \nFOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4  \nFenghua Bian 1,9, Chinmayee Goda 1,9, Guolun Wang1,9, Ying-Wei Lan1,2, Zicheng Deng1,2, Wen Gao 2, Anusha Acharya1, Abid A Reza 1, Jose Gomez-Arroyo1, Nawal Merjaneh3, Xiaomeng Ren 4, Jermaine Goveia5, Peter Carmeliet 5,6, Vladimir V Kalinichenko2,7 & Tanya V Kalin 1,2,3,8 ✉  \nAbstract  \nCancer cells re-program normal lung endothelial cells (EC) into tumor-associated endothelial cells (TEC) that form leaky vessels supporting carcinogenesis. Transcriptional regulators that control the reprogramming of EC into TEC are poorly understood. Weidentiﬁed Forkhead box F1 (FOXF1) as a critical regulator of EC-toTEC transition. FOXF1 was highly expressed in normal lung vasculature but was decreased in TEC within non-small cell lung cancers (NSCLC) . Low FOXF1 correlated with poor overall survival of NSCLC patients. In mice, endothelial-speciﬁc deletion of FOXF1 decreased pericyte coverage, increased vessel permeability and hypoxia, and promoted lung tumor growth and metastasis. Endothelial-speciﬁc overexpression of FOXF1 normalized tumor vessels and inhibited the progression of lung cancer. FOXF1 deﬁciency decreased Wnt/β-catenin signaling in TECs through direct transcriptional activation of Fzd4 . Restoring FZD4 expression in FOXF1-deﬁcient TECs through endothelial-speciﬁc nanoparticle delivery of Fzd4 cDNA rescued Wnt/β-catenin signaling in TECs, normalized tumor vessels and inhibited the progression of lung cancer. Altogether, FOXF1 increases tumor vessel stability, and inhibits lung cancer progression by stimulating FZD4/Wnt/β -catenin signaling in TECs. Nanoparticle delivery of FZD4 cDNA has promise for future therapies in NSCLC.  \nKeywords Tumor-Associated Endothelial Cells; Wnt Signaling; Fzd4; Foxf1; Nanoparticle Delivery System  \nSubject Categories Cancer; Respiratory System  \n[https://doi.org/10.1038/s44321-024-00064-8](https://doi.org/10.1038/s44321-024-00064-8)  \nReceived 24 July 2023; Revised 19 March 2024; Accepted 21 March 2024  \nPublished online: 8 April 2024  \nIntroduction  \nLung cancer is the leading cause of cancer-related mortality worldwide. Current treatment strategies include chemotherapy and/or radiotherapy, and surgery in the case of patients diagnosed with early-stage lung cancer. However, the 5-year survival rate of patients with advanced NSCLC remains less than 20%(Siegel et al, 2019), emphasizing a need to develop better treatment strategies. Interactions between the tumor microenvironment and tumor cells play a crucial role in tumor progression. Tumor cells secrete proangiogenic factors, like VEGF, that recruit endothelial cells to form tumor-associated vasculature, which provides nutrients and oxygen to the proliferating tumor cells, thereby supporting tumor growth. However, antiangiogenic therapies have failed to improve overall survival of lung cancer patients (Alshangiti et al, 2018), suggesting that a deeper understanding of tumor-associated vascular biology is required.  \nTumor-associated blood vessels are structurally and functionally abnormal. The presence of tumor cells induces reprogramming of normal endothelial cells (EC) into tumor-associated endothelial cells (TEC) (Dudley, 2012) . While ECs are quiescent and form tightendothelial barrier, TECs are activated and form leaky vessels that support carcinogenesis. Re-programmed TEC secrete protumorigenic mediators, supporting tumor cell proliferation and invasion (Maishi and Hida, 2017; Zhao et al, 2016). TEC are resting on a porous basement membrane with decreased pericyte coverage, causing increased vessel permeability. Increased vessel permeability induces tumor-associated inﬂammation and contributes to increased intravasation and extravasation of tumor cells, stimulating tumor invasion and metastasis (Kienast et al, 2010) . Perfusion through tumor-associated vessels is decreased, causing hypoxia within the tumors (Jain, 2014) . The hypoxic and ","cbCaitdJI55V4jWT","https://ap.wps.com/l/cbCaitdJI55V4jWT","pdf",19025999,28,"English","# Abstract\n# Introduction\n## Tumor microenvironment and vascular progression\n## Endothelial reprogramming and abnormal vessels\n# Vascular normalization and therapeutic implications","[{\"question\":\"What role does FOXF1 play in tumor-associated endothelial cells (TEC)?\",\"answer\":\"FOXF1 is a critical regulator of the EC-to-TEC transition. It supports tumor vessel stability and inhibits lung cancer progression by promoting downstream signaling.\"},{\"question\":\"How does FOXF1 loss affect lung tumors in vivo?\",\"answer\":\"Endothelial-specific deletion of FOXF1 decreases pericyte coverage, increases vessel permeability and hypoxia, and promotes lung tumor growth and metastasis.\"},{\"question\":\"How is FZD4 linked to FOXF1 and Wnt/β-catenin signaling?\",\"answer\":\"FOXF1 directly activates Fzd4 transcription in TECs, which increases Wnt/β-catenin signaling. Restoring FZD4 via endothelial nanoparticle delivery rescues signaling and normalizes tumor vessels.\"}]","FOXF1 promotes tumor vessel normalization and prevents lung cancer progression through FZD4 | PDF",1790041047,71,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f56064f7409170e61a87a03fe417e40b.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2dc30ff6f1026aa5199e6f741183550.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6e639321a8b2e17b97e98a9effead93.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e8acbc970032de224e4889e32239e41.webp",980,1301]